2015 ACAAI Virtual Annual Meeting

November 7, 2015 to November 8, 2015

Join the San Antonio
Meeting Virtually!

Two days of outstanding education for only $199
(and claim up to 15 CME credits)

Even if you can’t travel to San Antonio this year, you can “attend” the plenary and symposia on Saturday and Sunday using your PC or mobile device.

And you can claim up to 15 CME credits for your participation.

REGISTRATION CLOSED

When the event nears, this page will be updated with instructions on how to join the Virtual Meeting via Adobe Connect. The link and instructions will also be emailed to you at that time.

The virtual meeting will include:

  • Access to all the presentation slides from the virtual annual meeting
  • Live broadcast of the speakers and their slides from the Saturday (11/7) and Sunday (11/8) plenary and symposia sessions (see session listing below)
  • The ability to submit questions to be included during session Q&A
  • The ability to discuss topics with your fellow virtual participants
  • Access to the recordings of the sessions after the Annual Meeting concludes
  • This is a "live" webcast. CME credit will be claimed based on particpation in the webcast.

Virtual Annual Meeting Sessions:

  • Biologics in Practice:  Unique Opportunity for Allergist Expertise (Saturday, 8:30-10:30am Central)
  • The Sky is Not Falling: Flourishing Despite Tectonic Shifts to U.S. Health Care (Saturday, 11:00am-12:30pm Central)
  • The Great Raft Debate: Hottest Topic in EoE (Saturday, 1:30-3:00pm Central)
  • Altering the Natural History of Allergic Diseases with Immunotherapy (Saturday, 3:30-5:30pm Central)
  • Controversial Manifestations of Contact Dermatitis (Sunday, 8:30-10:00am Central)
  • Oh the Places You'll Go! Dr. Seuss Reminds Us About Paths to Take!  (Sunday, 10:30-11:00am Central)
  • Human Microbiome: The Interface of Immunology and Microbiology (Sunday, 11:00am-12:30pm Central)
  • ABAI/MOC: More Than Meeting the Test (Sunday, 1:30-3:30pm Central)
  • Severe Asthma: Persistent Challenges; New Therapies (Sunday, 4:00-6:00pm Central)

Accreditation

The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

This activity is supported by independent educational grants from Merck and Teva Respiratory.

Target Audience

  • All practicing allergists/immunologists
  • Fellows in allergy/immunology training programs
  • Primary care physicians who care for allergy patients
  • Allied health professionals in the field of allergy and immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract
  • Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency
  • Translate emerging clinical science principles to clinical practice in patients with allergic and immunologic diseases
  • Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergic and immunologic diseases
  • Explain the impact of environmental exposures and external influences on patients with allergic disorders
  • Recognize emerging trends in the prevalence of allergic and immunologic disorders and discuss their impact on public health
  • Evaluate the impact of new diagnostic and therapeutic strategies on health care costs and outcomes
  • Discuss processes, tools and technologies for the efficient allergy and immunology practice

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Cem Akin, MD, PhD
Consultant/Advisor: Blueprint Medicines, Novartis,
Patara Pharma; Supported/Contracted Research: Dyax
Thomas B. Casale, MD, FACAAI
Consultant/Advisor: AstraZeneca, Genentech, Novartis,
Sanofi, Teva
Craig A. Alter, MD
Consultant/Advisor: Pfizer
Bradley E. Chipps, MD, FACAAI
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, Genentech, Merck, Novartis; Speaker:
AstraZeneca, Boehringer Ingelheim, Genentech,
Merck, Novartis; Supported/Contracted Research:
Stallergenes
Leonard B. Bacharier, MD, FACAAI
Consultant/Advisor: Boehringer Ingelheim, DBV
Technologies, GlaxoSmithKline, Meda,Teva; Speaker:
AstraZeneca, Novartis
Ray S. Davis, MD, FACAAI
Consultant/Advisor: Alcon, AstraZeneca, Baxter, Meda,
Merck, Teva
Mark M. Ballow, MD, FACAAI
Consultant/Advisor: CSL Behring, Kedrion; Supported/
Contracted Research: CSL Behring; Speaker: Baxter
§ Chitra Dinakar, MD, FACAAI
Consultant/Advisor: Aerocrine; Supported/Contracted
Research: GlaxoSmithKline, Merck, Teva
Gregory W. Bensch, MD, FACAAI
Consultant/Advisor: AstraZeneca, Teva; Supported/
Contracted Research: AstraZeneca, Boehringer
Ingelheim, Pearl, Teva
Mark S. Dykewicz, MD, FACAAI
Consultant/Advisor: Merck; Supported/Contracted
Research: Novartis
J. Andrew Bird, MD, FACAAI
Speaker: Nutrica; Supported/Contracted Research:
Aimmune Therapeutics, DBV Technologies
David B. Engler, MD, FACAAI
Stock: Regeneron
Mark Boguniewicz, MD, FACAAI
Consultant/Advisor: Celgene, Regeneron; Supported/
Contracted Research: Anacor
Elizabeth A. Erwin, MD
Stock: Pfizer
Larry Borish, MD, FACAAI
Consultant/Advisor: Allakos, Knopp, Novartis,
PluriStem
Stanley M. Fineman, MD, MBA, FACAAI
Speaker: AstraZeneca, Genentech, Meda, Merck,
Mylan; Supported/Contracted Research: Genentech,
Meda
John C. Browning, MD, MBA
Supported/Contracted Research: Anacor, MedImmune,
Regeneron
David M. Fleisher, MD
Consultant/Advisor: Food Allergy Research &
Education, LabCorp, National Peanut Board,
Receptors, Nestle Nutrition Institute; Supported/
Contracted Research: Monsanto Company, Nestle
Nutrition Institute
A. Wesley Burks, MD, FACAAI
Consultant/Advisor: Dynavax Technologies,
Genentech, GLG Research, Intrexon, Perrigo,
Perosphere, Regeneron, SRA International, Sanofi,
Valeant; Board Member (for profit organization)
Stallergenes
§ Luz S. Fonacier, MD, FACAAI
Speaker: Baxter; Supported/Contracted Research:
Baxter, Genentech, Merck
§ B. Gwen Carlton, DNP, APRN, FNP-BC
Speaker: Genentech
David M. Lang, MD, FACAAI
Consultant/Advisor: Genentech, GlaxoSmithKline,
Meda, Merck; Speaker: Genentech; Supported/
Contracted Research: Genentech, Merck
Lene Heise Garvey, MD, PhD
Consultant/Advisor: Merck; Speaker: Thermo Fisher
Scientific
Bob Lanier, MD, FACAAI
Supported/Contracted Research: Merck, Novartis,
Teva; Speaker: Genentech, Merck
Maureen George, PhD, RN, AE-C
Consultant/Advisor: Teva; Speaker: Teva
§ Phillip L. Lieberman, MD, FACAAI
Consultant/Advisor: Genentech, Mylan, Teva, Valeant;
Speaker: Meda
§ Richard G. Gower, MD, FACAAI
Consultant/Advisor: CSL Behring, Dyax, Mylan, Shire,
Teva; Medical Director: HollisterStier; Speaker: CSL
Behring, Mylan, Shire, Teva; Supported/Contracted
Research: Anacor, Biocryst, Circassia, CSL Behring,
Dyax, Genentech, GlaxoSmithKline, Kedrion, Mylan,
Optinose, Pearl, Regeneron, Shire, Teva; Stock: Merck
Peter A. Lio, MD
Consultant/Advisor: Anacor, Galderma, Johnson &
Johnson, Pierre Fabre, Valeant
David F. Graft, MD, FACAAI
Consultant/Advisor: Aerocrine; Speaker: Merck
William R. Lumry, MD, FACAAI
Consultant/Advisor: Biocryst, CSL Behring, Dyax, Shire;
Speaker: CSL Behring, Dyax, Shire, Teva; Supported/
Contracted Research: ADMA Biologics, Biocryst,
Circassia, CSL Behring, Dyax, Kedrion, Mylan, Novartis,
Roche, Shire, Teva
Mitchell H. Grayson, MD, FACAAI
Supported/Contracted Research: Polyphor
§ Todd A. Mahr, MD, FACAAI
Speaker: Aerocrine, Genentech, GlaxoSmithKline,
Meda, Merck, Mylan, Sanofi, Teva
§ Matthew Greenhawt, MD, MBA, MSc, FACAAI
Consultant/Advisor: National Peanut Board;
Supported/Contracted Research: National Center for
Translational Sciences
Michael E. Manning, MD, FACAAI
Consultant/Advisor: Dyax, Shire; Speaker: Baxter, CSL
Behring, Dyax, Genentech, Merck, Shire; Supported/
Contracted Research: Amgen, AstraZeneca, Biocryst,
Dyax, Genentech, Janssen, Johnson & Johnson,
Merck, Novartis, Sanofi, Shire, Teva
Gary N. Gross, MD, FACAAI
Supported/Contracted Amgen, Genentech, Janssen,
Mylan, Perrigo, Sanofi, Teva; Speaker: Merck, Teva
Kelly M. Maples, MD, FACAAI
Speaker: Teva
Ruchi Gupta, MD, MPH
Speaker: Mylan Specialty; Supported/Contracted
Research: Food Allergy Research & Education, Mylan
Gailen D. Marshall, MD, PhD, FACAAI
Supported/Contracted Research: Amgen, AstraZeneca,
National Institutes of Health (NIH)
Nicola A. Hanania, MD, MS
Consultant/Advisor: AstraZeneca, Meda, Novartis,
Pfizer, Roche, Sunovion; Speaker: Genentech;
Supported/Contracted Research: Boehringer
Ingelheim, Chiesi, Genentech, GlaxoSmithKline, Mylan,
Novartis, Pfizer, Roche, Sunovion
• § Kevin P. McGrath, MD FACAAI
Speaker: Teva
Mary Lou Hayden, MSN, FNP-BC, AE-C
Consultant/Advisor: Boehringer Ingelheim, Mylan, Teva
J. Allen Meadows, MD, FACAAI
Consultant/Advisor: Pfizer; Stocks: Johnson & Johnson
Erika Jensen-Jarolim, MD
Speaker: Allergy Therapeutics, Meda, Roxall, Thermo
Fisher Scientific; Stocks: Biomedical International R&D
Vienna, AllergyCare Vienna
Eli O. Meltzer, MD, FACAAI
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, Circassia, GlaxoSmithKline, Greer, Johnson
& Johnson, McNeill, Meda, Merck, Regeneron, Sanofi,
Sunovion, Teva, Takeda, Valeant; Speaker: Alcon,
Greer, Meda, Mylan, Sunovion, Teva, Takeda
§ Rohit K. Katial, MD, FACAAI
Consultant/Advisor: AstraZeneca, GlaxoSmithKline,
Meda, Teva; Speaker: GlaxoSmithKline, Meda
Anthony Montanaro, MD, FACAAI
Supported/Contracted Reearch: Circassia, Genentech,
GlaxoSmithKline, Merck, Teva
§ David A. Khan, MD, FACAAI
Speaker: Baxter, Genentech
Harold S. Nelson, MD, FACAAI
Consultant/Advisor: AstraZeneca, Circassia, Merck,
Pearl Therapeutics; Supported/Contracted Research:
Circassia
Lisa K. Kobrynski, MD, MPH, FACAAI
Supported/Contracted Research: Baxter; Speaker:
Baxter, CSL Behring
William S. Silvers, MD, FACAAI
Speaker: Teva
Jerald W. Koepke, MD, FACAAI
Supported/Contracted Research: Sanofi
Roland Solensky, MD
Supported/Contracted Research: AstraZeneca, Merck
Anna H. Nowak-Wegrzyn, MD, FACAAI
Consultant/Advisor: Merck, Nestle; Speaker: Sanofi;
Supported/Contracted Research: DBV Technologies,
Food Allergy Research & Education, NIH/NIAID, ITN,
Nutricia
§ Brett Stanaland, MD, FACAAI
Speaker: Alcon, Meda, Merck, Teva
Talal M. Nsouli, MD, FACAAI
Consultant/Advisor: Teva; Speaker: Perrigo, Thermo
Fisher Scientific
§ James L. Sublett, MD, FACAAI
Consultant/Advisor: Boston Scientific, Greer;
Speaker: Genentech, GlaxoSmithKline, Meda, Merck,
Sunovion, Teva; Supported/Contracted Research:
Array BioPharma, AstraZeneca, Boehringer Ingelheim,
Forest, Mylan, Sanofi: Stock: AllergyZone
§ Maeve E. O’Connor, MD, FACAAI
Consultant/Advisor: Novartis; Speaker: Aerocrine,
Baxter, Dyax, Greer, Meda, Merck, Mylan, Teva,
Thermo Fisher Scientific
§ Stephen A. Tilles, MD, FACAAI
Supported/Contracted Research: Amgen, Astellas,
AstraZeneca, Biota, Circassia, DBV Technologies,
Genentech, Merck, Mylan, Novartis, Perrigo, Teva
§ John J. Oppenheimer, MD, FACAAI
Consultant/Advisor: GlaxoSmithKline, Meda, Mylan;
Supported/Contracted Research: AstraZeneca,
MedImmune, Novartis
James M. Tracy, DO, FACAAI
Consultant/Advisor: Johnson and Johnson, Pfizer;
Stock: Johnson & Johnson
Jordan S. Orange, MD, PhD, FACAAI
Consultant/Advisor: ADMA Biologics, ASD Healthcare,
Baxter, CSL Behring, Walgreens
Carina Venter, PhD, RD
Consultant/Advisor: Mead Johnson, Nestle; Speaker:
Nutricia; Supported/Contracted Research: Thermo
Fisher Scientific
Reynold A. Panettieri, Jr., MD
Consultant/Advisor: AstraZeneca, Johnson & Johnson;
Supported/Contracted Research: Gilead, Johnson &
Johnson, Merck, Roche, Sanofi
Christine W. Wagner, MSN, RN, CPNP, AE-C
Speaker: Teva
Anju T. Peters, MD, FACAAI
Consultant/Advisor: Baxter, Greer, Meda; Speaker:
Celgene
Julie Wang, MD, FACAAI
Consultant/Advisor: JDP Therapeutics, Merck
Stephen P. Peters, MD, PhD
Consultant/Advisor: AstraZeneca, Boehringer
Ingelheim, CSL Behring, Gilead, Merck, Novartis,
Pfizer, Teva, PPD Development, Quintiles, Theron
Richard L. Wasserman, MD, PhD, FACAAI
Consutlant/Advisor: ADMA Biologics, Baxter, Bio
Products Lab, CSL Behring, Grifols, Kedrion, ProMetic,
Therapure Biopharma; Speaker: Baxter, CSL Behring;
Supported/Contracted Research: ADMA Biologics,
Baxter, Bio Products Labs, CSL Behring, Kedrion,
Merck, Perrigo, Sanofi, Teva
§ Michael Pistiner, MD, MMSc, FACAAI
Stock: AllergyHome.org
Stephen I. Wasserman, MD, FACAAI
President: ABAI; consultant(sp): Pathway Genomics
Jay M. Portnoy, MD, FACAAI
Speaker: Mylan, Thermo Fisher Scientific
Richard W. Weber, MD, FACAAI
Consultant/Advisor: Genentech; Speaker: AstraZeneca,
Meda, Merck
Marc A. Riedl, MD, MS
Consultant/Advisor: Baxter, BioCryst, CSL Behring,
Dyax, Salix, Shire: Speaker: Baxter, CSL Behring, Dyax,
Salix, Shire: Supported/Contracted Research: Amgen,
Biocryst, CSL Behring, Dyax, Shire
Bruce L. Zuraw, MD, FACAAI
Consultant/Advisor: BioCryst, CSL Behring, Dyax,
Genentech, Isis, Novartis, Sanofi, Shire
§ Deidra H. Sanders, MSN, APRN, FNP-BC
Consultant/Advisor: Meda; Stock: AllergyZone
 
§ Charles J. Siegel, MD, FACAAI
Consultant/Advisor: Meda; Speaker: Meda, Teva
 
  
• = Planner §= Moderator 


The following have no financial relationships to disclose:

Juan Adams, MDNabeel Farooqui, MD
Karla Adams, MDTracy Fausnight, MD, FACAAI
David B. Allen, MDAlessandro Fiocchi, MD, FACAAI (SC)
§ Amal H. Assa’ad, MD, FACAAI§ Michael B. Foggs, MD, FACAAI
§ Sami L. Bahna, MD, DrPH, FACAAI§ Karen A. Freedle, MD, FACAAI
Aleena Banerji, MDTheodore M. Freeman, MD, FACAAI
Charles Barnes, PhDMarianne N. Frieri, MD, PhD, FACAAI
Rachel Bean, MDPinkus Goldberg, MD, FACAAI
Avraham Beigelman, MDPaul A. Greenberger, MD, FACAAI
Joseph A. Bellanti, MD, FACAAIMagdalena Grzyb, MD
• § Cheryl K. Bernstein, BSN, RN, CCRCMalike Gupta, MD
• § David I. Bernstein, MD, FACAAIDaniel L. Hamilos, MD, FACAAI
Leonard Bielory, MD, FACAAII. Celine Hanson, MD, FACAAI
§ Theresa A. Bingemann, MD, FACAAIJill Hanson, MD
Cheryl Blackwell, BSN, RN, AE-CCurtis Hedberg, MD, FACAAI
Hannelore A. Brucker, MD, FACAAI (SC)Alice Hoyt, MD
Paula Busse, MDFred H. Hsieh, MD, FACAAI
Ronna L. Campbell, MD, PhDKuan-Hsiang G. Huang, MD, PhD
Mariana C. Castells, MD, PhD, FACAAIYvonne Huang, MD
§ Helen Hei-ling Chan, MD, FACAAIElliot Israel, MD
Mirna Chehade, MD, MPH• Charlotte M. Jacobsen, MSN, RN
Meng Chen, MDJaison Jose, DO
Robert Chiffelle, MHSARobert J. Karman, MD
Seong H. Cho, MDMichael D. Keller, MD
Melanie Chong, MD• John M. Kelso, MD, FACAAI
Christina E. Ciaccio, MD, MSc, FACAAIRebecca Koransky, MD
• Kimberly G. Clay, MN, APRN, FNP-BC• Tao T. Le, MD, MHS, FACAAI
David E. Cohen, MD§ Gerald B. Lee, MD
Kevin Cook, MDRobert F. Lemanske, MD, FACAAI
• Mark L. Corbett, MD, FACAAI• § James T. Li, MD, PhD, FACAAI
• Peter S. Creticos, MDSamantha Lin, MD
Howard C. Crisp, MDBaojuan Liu
Mark A. Davis-Lorton, MD, FACAAI• § Bryan L. Martin, DO, FACAAI
Ves Dimov, MDFernando D. Martinez, MD
Nicholas DitzlerHannia Matt, MD
• § William K. Dolen, MD, FACAAIStephanie Mawhirt, DO
Steve Dorman, MDJacek Mazurek, MD
Dumitru Moldovan, MDPeter C. Schalock, MD
• Kevin R. Murphy, MD, FACAAI (SC)William T. Shearer, MD, PhD
Kari C. Nadeau, MD, PhDMichael Sherenian, MD
Naveen Nannapaneni, MD• § Jodi Shroba, MSN, APRN, CPNP
Maya Nanda, MD, MScMili Shum, MD
Elham A. Nekoo, MDWilliam S. Silvers, MD
Michael R. Nelson, MD, PhD, FACAAIDavid P. Skoner, MD, FACAAI
Victoria NelsonRaymond S. Slavin, MD, FACAAI
• § Andrew Nickels, MD• Sheldon L. Spector, MD, FACAAI
Noreen H. Nicol, PhD, RN, FNP, NEA-BCJonathan M. Spergel, MD, PhD, FACAAI
Irum Noor, DOSarah Spriet, DO
Lois M. Nora, MD, JD, MBAWhitney Stevens, MD, PhD
Safa Nsouli, MDPatricia H. Stewart, MD
Mark T. O’Hollaren, MD, FACAAIJames W. Sublett, MD, FACAAI
Grant C. Olson, MD, FACAAIMichael S. Tankersley, MD, FACAAI
Roy A. Orden, MDJames S. Taylor, MD
Thamiris Palacios, DOMary C. Tobin, MD, FACAAI
Dipika R. Patel, MDStephen K. Tsui, PhD
Neha N. Patel, MDJanna M. Tuck, MD, FACAAI
Priya Patel, MDJoseph C. Turbyville MD, FACAAI
Sheenal Patel, MD• Kay Tyler, BS, BA, MBA
David L. Patterson, MD, MBA, MS, FACAAIPeter Vadas, MD, PhD
Tammy Peng, MD• § Dana V. Wallace, MD, FACAAI
Maureen M. Petersen, MD, FACAAIKathryn R. Wessell, DO
Thomas A. Platts-Mills, MD, FACAAIC. Ross Westley, MD, FACAAI
Brooke I. Polk, MDMartha White, MD, FACAAI
Donald W. Pulver, MD, FACAAIP. Brock Williams, PhD, FACAAI (SC)
Vijay Ramakrishnan, MDAndrew Winslow, MD
Avner Reshef, MDPriscilla Wong, MD
Lanny J. Rosenwasser, MD, FACAAIShijun Xi, MD
• John M. Routes, MD, FACAAIKenneth Yeager, PhD
Tara V. Saco, MDCherie Y. Zachary, MD, FACAAI
Steve Shah, MDMyron Zitt, MD, FACAAI
  
• = Planner §= Moderator 

























• = Planner §= Moderator

Course summary
Available credit: 
  • 15.00 AMA PRA Category 1 Credit™
  • 15.00 Attendance
Course opens: 
09/30/2015
Course expires: 
12/01/2016
Event starts: 
11/07/2015 - 8:30am
Event ends: 
11/08/2015 - 6:00pm
Cost:
$299.00
Rating: 
3
Virtual Meeting
San Antonio, TX 78205
United States

Available Credit

  • 15.00 AMA PRA Category 1 Credit™
  • 15.00 Attendance

Accreditation Period

Course opens: 
09/30/2015
Course expires: 
12/01/2016

Price

Cost:
$299.00
Please login or create an account to take this course.

Required Hardware/software

System Requirements to Attend:

  • On a Windows or Macintosh PC:
    • Web browser (Internet Explorer, Chrome, Safari, Firefox, etc.)
    • Speakers or headphones for audio
    • Internet connection
  • On an iOS or Android Mobile Device:
    • The Adobe Connect app (available from iTunes App Store or Google Play)
    • Internet connection